Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Savara Price to Book Ratio 2010-2025 | SVRA

Historical price to book ratio values for Savara (SVRA) over the last 10 years. The current price to book ratio for Savara as of July 24, 2025 is 2.98.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
Savara Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2025-07-25 2.58 3.01
2025-03-31 2.77 $0.86 3.24
2024-12-31 3.07 $0.99 3.09
2024-09-30 4.24 $1.17 3.63
2024-06-30 4.03 $0.74 5.47
2024-03-31 4.98 $0.88 5.65
2023-12-31 4.70 $1.02 4.63
2023-09-30 3.78 $1.08 3.49
2023-06-30 3.20 $0.77 4.16
2023-03-31 1.95 $0.86 2.26
2022-12-31 1.55 $0.95 1.64
2022-09-30 1.55 $1.02 1.52
2022-06-30 1.52 $1.11 1.36
2022-03-31 1.31 $1.20 1.09
2021-12-31 1.24 $1.27 0.98
2021-09-30 1.38 $1.36 1.01
2021-06-30 1.70 $1.45 1.17
2021-03-31 2.08 $1.54 1.35
2020-12-31 1.15 $1.19 0.97
2020-09-30 1.09 $1.42 0.77
2020-06-30 2.49 $1.59 1.57
2020-03-31 2.12 $1.72 1.23
2019-12-31 4.48 $2.00 2.24
2019-09-30 2.65 $2.59 1.02
2019-06-30 2.37 $2.90 0.82
2019-03-31 7.37 $2.84 2.59
2018-12-31 7.57 $3.08 2.46
2018-09-30 11.16 $3.36 3.33
2018-06-30 11.32 $2.68 4.22
2018-03-31 9.20 $3.06 3.00
2017-12-31 14.84 $3.91 3.79
2017-09-30 9.35 $3.06 3.05
2017-06-30 5.88 $3.30 1.78
2017-03-31 8.65 $1.20 7.23
2016-12-31 6.08 $2.52 2.41
2016-09-30 7.70 $3.96 1.94
2016-06-30 32.90 $5.51 5.97
2016-03-31 19.10 $7.50 2.55
2015-12-31 29.42 $10.21 2.88
2015-09-30 40.60 $14.33 2.83
2015-06-30 34.30 $18.18 1.89
2015-03-31 33.95 $21.97 1.55
2014-12-31 39.20 $25.72 1.52
2014-09-30 38.99 $24.82 1.57
2014-06-30 44.03 $29.30 1.50
2014-03-31 47.60 $32.46 1.47
2013-12-31 32.37 $32.55 0.99
2013-09-30 30.73 $36.13 0.85
2013-06-30 30.04 $39.42 0.76
2013-03-31 47.27 $55.25 0.86
2012-12-31 39.90 $63.17 0.63
2012-09-30 50.41 $67.84 0.74
2012-06-30 35.70 $71.93 0.50
2012-03-31 48.30 $77.61 0.62
2011-12-31 41.30 $83.21 0.50
2011-09-30 64.40 $114.02 0.56
2011-06-30 210.70 $122.59 1.72
2011-03-31 147.00 $132.45 1.11
2010-12-31 182.70 $120.55 1.52
2010-09-30 142.80 $136.94 1.04
2010-06-30 114.10 $144.99 0.79
2010-03-31 381.15 $127.97 2.98
2009-12-31 612.33 $56.84 10.77
2009-09-30 262.50 $22.75 11.54
2009-06-30 253.93 $37.06 6.85
2009-03-31 306.25 $58.35 5.25
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.441B $0.000B
Savara Inc. is a clinical-stage pharmaceutical company. It focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Savara Inc., formerly known as Mast Therapeutics, Inc., is based in Austin, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.478B 30.57
Zoetis (ZTS) United States $68.037B 25.39
Daiichi Sankyo, - (DSNKY) Japan $46.885B 24.03
Takeda Pharmaceutical (TAK) Japan $46.647B 9.28
BeOne Medicines - (ONC) Cayman Islands $32.492B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.501B 0.00
Summit Therapeutics (SMMT) United States $20.475B 0.00
Merck (MKKGY) Germany $17.325B 12.69
Shionogi (SGIOY) Japan $14.589B 14.62
United Therapeutics (UTHR) United States $13.821B 12.23
Neurocrine Biosciences (NBIX) United States $13.028B 44.62
Orion OYJ (ORINY) Finland $11.714B 28.23
IPSEN (IPSEY) France $11.064B 0.00
Stevanato Group S.p.A (STVN) Italy $8.464B 51.76
Corcept Therapeutics (CORT) United States $7.168B 58.27
Grifols, S.A (GRFS) Spain $6.834B 0.00
Ionis Pharmaceuticals (IONS) United States $6.709B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.643B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.204B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.436B 0.00
Hypermarcas (HYPMY) Brazil $3.085B 20.29
Crinetics Pharmaceuticals (CRNX) United States $2.847B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.626B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.564B 8.98
Procaps Group, S.A (PROCF) Luxembourg $2.534B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.507B 13.56
Centessa Pharmaceuticals (CNTA) United Kingdom $2.067B 0.00
Ocular Therapeutix (OCUL) United States $1.899B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.789B 0.00
ARS Pharmaceuticals (SPRY) United States $1.760B 0.00
Endo (NDOI) United States $1.755B 0.00
Evotec AG (EVO) Germany $1.438B 0.00
Harrow (HROW) United States $1.366B 0.00
Guardian Pharmacy Services (GRDN) United States $1.283B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.225B 24.51
Avadel Pharmaceuticals (AVDL) Ireland $1.088B 0.00
Enliven Therapeutics (ELVN) United States $1.077B 0.00
Dyne Therapeutics (DYN) United States $1.050B 0.00
Ardelyx (ARDX) United States $1.043B 0.00
Collegium Pharmaceutical (COLL) United States $1.032B 5.57
Akebia Therapeutics (AKBA) United States $1.009B 0.00
Verve Therapeutics (VERV) United States $0.992B 0.00
ProKidney (PROK) United States $0.954B 0.00
Xeris Biopharma Holdings (XERS) United States $0.809B 0.00
Cronos Group (CRON) Canada $0.798B 0.00
KalVista Pharmaceuticals (KALV) United States $0.779B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.740B 0.00
Xencor (XNCR) United States $0.658B 0.00
Zevra Therapeutics (ZVRA) United States $0.638B 0.00
Relay Therapeutics (RLAY) United States $0.631B 0.00
Organogenesis (ORGO) United States $0.603B 0.00
USANA Health Sciences (USNA) United States $0.598B 12.02
Elite Pharmaceuticals (ELTP) United States $0.580B 0.00
Theravance Biopharma (TBPH) United States $0.557B 0.00
Oruka Therapeutics (ORKA) United States $0.533B 0.00
Bioventus (BVS) United States $0.526B 13.33
Siga Technologies (SIGA) United States $0.504B 10.54
Tourmaline Bio (TRML) United States $0.482B 0.00
Aquestive Therapeutics (AQST) United States $0.417B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.365B 9.87
AleAnna (ANNA) United States $0.357B 0.00
Altimmune (ALT) United States $0.333B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.329B 0.00
Aldeyra Therapeutics (ALDX) United States $0.326B 0.00
Nanobiotix S.A (NBTX) France $0.306B 0.00
Nektar Therapeutics (NKTR) United States $0.305B 0.00
Esperion Therapeutics (ESPR) United States $0.295B 0.00
Heron Therapeutics (HRTX) United States $0.290B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.20
OmniAb (OABI) United States $0.259B 0.00
Larimar Therapeutics (LRMR) United States $0.240B 0.00
MediWound (MDWD) Israel $0.225B 0.00
Liminatus Pharma (LIMN) United States $0.220B 0.00
4D Molecular Therapeutics (FDMT) United States $0.214B 0.00
China SXT Pharmaceuticals (SXTC) China $0.188B 0.00
Galectin Therapeutics (GALT) United States $0.186B 0.00
Aclaris Therapeutics (ACRS) United States $0.182B 0.00
Journey Medical (DERM) United States $0.179B 0.00
Profound Medical (PROF) Canada $0.177B 0.00
Avita Medical (RCEL) United States $0.158B 0.00
Lyell Immunopharma (LYEL) United States $0.154B 0.00
Korro Bio (KRRO) United States $0.149B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.133B 0.00
Protara Therapeutics (TARA) United States $0.129B 0.00
Lexeo Therapeutics (LXEO) United States $0.122B 0.00
Cassava Sciences (SAVA) United States $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.110B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Nutriband (NTRB) United States $0.098B 0.00
Vivani Medical (VANI) United States $0.095B 0.00
Metagenomi (MGX) United States $0.094B 0.00
Achieve Life Sciences (ACHV) Canada $0.094B 0.00
Fractyl Health (GUTS) United States $0.094B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Champions Oncology (CSBR) United States $0.092B 20.78
ESSA Pharma (EPIX) Canada $0.083B 0.00
Pyxis Oncology (PYXS) United States $0.083B 0.00
Inotiv (NOTV) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Surrozen (SRZN) United States $0.076B 0.00
Context Therapeutics (CNTX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Rafael Holdings (RFL) United States $0.074B 0.00
Dominari Holdings (DOMH) United States $0.073B 0.00
Assertio Holdings (ASRT) United States $0.072B 0.00
Avalo Therapeutics (AVTX) United States $0.072B 0.00
Wellgistics Health (WGRX) United States $0.068B 0.00
Telomir Pharmaceuticals (TELO) United States $0.068B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Klotho Neurosciences (KLTO) United States $0.058B 0.00
Century Therapeutics (IPSC) United States $0.057B 0.00
ElectroCore (ECOR) United States $0.056B 0.00
Jupiter Neurosciences (JUNS) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 37.33
Incannex Healthcare (IXHL) Australia $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Plus Therapeutics (PSTV) United States $0.036B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Vivos Therapeutics (VVOS) United States $0.032B 0.00
FibroGen (FGEN) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
DURECT (DRRX) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 2.65
BioVie (BIVI) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.83
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00